J01DD04 |
B |
Ceftriaxone (sodium) - 1g |
1570 |
25468 |
ROCEPHIN IV |
1g |
1 x 10ml |
Injectable lyophilised powder for solution+diluent |
Infusion/IV |
Omnipharma |
F. Hoffmann La Roche Ltd |
Switzerland |
757,927 L.L |
23.08 |
A2 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
755 |
208619/03 |
AXONE |
1g |
10 |
Injectable powder for solution |
Infusion/IV |
Picomed SARL |
Pharma International Co |
Jordan |
4,053,029 L.L |
23.08 |
B |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
1617 |
236978/99 |
TRIAXONE |
1g |
1 |
Injectable powder for solution |
IM |
Pharmanet Drugstore S.A.R.L. |
Julphar |
United Arab Emirates |
438,093 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
2271 |
973948/02 |
CEFTRIAXONE PANPHARMA |
1g |
25 |
Injectable powder for solution |
Infusion/IV/IM |
Minapharm Halabi |
Panpharma |
France |
8,005,714 L.L |
21.26 |
C |
Panpharma |
France |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
2332 |
974033/02 |
VERACOL |
1g |
1 x 10ml |
Injectable lyophilised powder for solution+diluent |
Infusion/IV |
Macromed S.A.R.L. |
Demo SA |
Greece |
454,219 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
3263 |
208382/02 |
TRAVILAN IM |
1g |
1 x 3.5ml |
Injectable lyophilised powder for solution+diluent |
IM |
Medi drug International SAL (MDI) |
Anfarm Hellas SA |
Greece |
438,093 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (disodium) - 1g |
5201 |
194126/05 |
MEDAXONUM |
1g |
1 |
Injectable powder for solution+diluent |
IM |
New Allpharma |
Medochemie Ltd |
Cyprus |
438,093 L.L |
23.08 |
A1 |
Medochemie Ltd |
Cyprus |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
5716 |
219715/09 |
TRIAXONE |
1g |
10 |
Injectable powder for solution |
IV/IM |
Pharmanet Drugstore S.A.R.L. |
Julphar |
United Arab Emirates |
4,542,188 L.L |
23.08 |
B |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (disodium) - 1g |
6912 |
96709/12 |
MEDAXONUM |
1g |
50 |
Injectable powder for solution |
Infusion/IV/IM |
New Allpharma |
Medochemie Ltd |
Cyprus |
15,482,229 L.L |
19.35 |
D |
Medochemie Ltd |
Cyprus |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
7779 |
87414/1 |
MESPORIN-1000 IV |
1,000mg |
1 x 10ml |
Injectable powder for solution+diluent |
Infusion/IV |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Portugal |
417,935 L.L |
23.08 |
A1 |
Acino AG |
Germany |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
7923 |
106514/1 |
MESPORIN-1000 IM |
1,000mg |
1 x 3.5ml |
Injectable powder for solution+diluent |
IM |
Mectapharm S.A.L. |
Labesfal Laboratorios Almiro SA |
Portugal |
417,935 L.L |
23.08 |
A1 |
Acino AG |
Germany |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g |
9127 |
187458/13 |
ROCICARE |
1g |
50 |
Injectable powder for solution |
IV/IM |
Drugstore 3U S.A.R.L. |
Swiss Exports PVT - Ltd |
India |
9,382,061 L.L |
21.26 |
C |
Swiss Exports PVT - Ltd |
India |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
9696 |
67018/1 |
AXONE 1G IM |
1g |
1+1 |
Injectable powder for solution+diluent |
IM |
Picomed SARL |
Pharma International Co |
Jordan |
438,093 L.L |
23.08 |
A1 |
Pharma International Co |
Jordan |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g |
11583 |
66822/1 |
CEFAXONE |
1g |
1 |
Injectable powder |
IM |
PMD (Pharmacist's medical drugstore) |
Unimed Laboratories |
Tunisia |
403,153 L.L |
23.08 |
A1 |
Unimed Laboratories |
Tunisia |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g |
11835 |
69724/1 |
CEFAXONE IM/IV |
1g |
10 |
Injectable lyophilised powder for solution |
IV/IM |
PMD (Pharmacist's medical drugstore) |
Unimed Laboratories |
Tunisia |
3,628,375 L.L |
23.08 |
B |
Unimed Laboratories |
Tunisia |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g |
11836 |
69524/1 |
CEFAXONE IV |
1g |
1 |
Injectable lyophilised powder for solution+diluent |
IV/IM |
PMD (Pharmacist's medical drugstore) |
Unimed Laboratories |
Tunisia |
403,153 L.L |
23.08 |
A1 |
Unimed Laboratories |
Tunisia |
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
6784 |
97385/12 |
LEBACEF |
1g |
1 x 10ml |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
643,765 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - |
6785 |
97384/12 |
LEBACEF |
1g |
1 x 3.5ml |
Injectable powder for solution+diluent |
IM |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
568,253 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
6892 |
97493/12 |
LEBACEF |
1g |
10 |
Injectable powder for solution |
IV/IM |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
5,793,881 L.L |
23.08 |
B |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
7617 |
45614/1 |
LEBACEF |
1g |
1 x 10ml |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
508,100 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g/3.5ml, Lidocaine (ampoule) - |
7818 |
69714/1 |
MEGION-A |
1g/3.5ml |
1 x 3.5ml |
Injectable powder + solvent |
IM |
Khalil Fattal & Fils S.A.L. |
Pharmaline under license from Sandoz GmbH, Austria |
Lebanon |
567,731 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (disodium 3.5 hydrate) - 1g |
9144 |
161716/1 |
MEGION |
1g |
1 x 10ml |
Injectable powder for solution+diluent |
Infusion/IV/IM |
Khalil Fattal & Fils S.A.L. |
Pharmaline Licensed by Sandoz GmbH, KUNDL, Austria |
Lebanon |
522,803 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g |
10075 |
152519/1 |
LEBACEF |
1g |
1+1 |
Injectable sterile powder for solution + lidocaine solvent |
IM |
Raymond Georges Abou Adal & Co |
Mitim SRL Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
508,100 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone - 1g |
10928 |
50622/1 |
LEBACEF |
1g |
1+1 |
Injectable sterile powder for solution + lidocaine solvent |
IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
508,100 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
10929 |
50422/1 |
LEBACEF |
1g |
1 |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
508,100 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
10930 |
50222/1 |
LEBACEF |
1g |
10 |
Injectable powder for solution |
IV/IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
5,793,881 L.L |
23.08 |
B |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
10931 |
50522/1 |
LEBACEF |
1g |
1 x 10ml |
Injectable powder for solution+diluent |
IV |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
643,765 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) - |
10932 |
50322/1 |
LEBACEF |
1g |
1 x 3.5ml |
Injectable powder for solution+diluent |
IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
568,253 L.L |
23.08 |
A1 |
|
|
12/12/20 |
0 |
J01DD04 |
G |
Ceftriaxone (sodium) - 1g |
11720 |
FE9924/1 |
LEBACEF |
1g |
10 |
Injectable powder for solution |
IV/IM |
Raymond Georges Abou Adal & Co |
ACS Dobfar SpA, Italy for Arwan Pharmaceutical Industries Lebanon SAL |
Lebanon |
5,793,881 L.L |
23.08 |
B |
|
|
12/12/20 |
0 |